{"name": "Syros Pharmaceuticals",
 "permalink": "syros-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/syros-pharmaceuticals",
 "homepage_url": "http://syros.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2013,
 "founded_month": 4,
 "founded_day": 16,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "Infor@syros.com",
 "phone_number": "617.744.1340",
 "description": "",
 "created_at": "Sat Apr 13 03:01:13 UTC 2013",
 "updated_at": "Tue Apr 16 10:55:11 UTC 2013",
 "overview": "\u003Cp\u003ESyros Pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression.  Syros has pioneered world-leading gene control research and drug discovery capabilities with a proven ability to integrate disease biology and genomic data\u0026#8211;a proficiency that is not well represented in pharmaceutical R\u0026amp;D.\u003C/p\u003E\n\n\u003Cp\u003ECentral to the Syros approach is a proprietary platform of carefully integrated assay technologies, bioinformatics, and biologic insights developed by members of Syros\u0026#8217; senior leadership.  While this scientific approach has applications in many therapeutic areas, Syros has demonstrated success initially in oncology, where it may help address numerous unmet medical needs.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       30],
      "assets/images/resized/0025/1152/251152v1-max-150x150.png"],
     [[250,
       51],
      "assets/images/resized/0025/1152/251152v1-max-250x250.png"],
     [[340,
       70],
      "assets/images/resized/0025/1152/251152v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Nancy",
      "last_name": "Simonian",
      "permalink": "nancy-simonian",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Gregg",
      "last_name": "Beloff",
      "permalink": "gregg-beloff",
      "image": null}},
   {"is_past": false,
    "title": "SAB member",
    "person":
     {"first_name": "Mark",
      "last_name": "Murcko",
      "permalink": "mark-murcko",
      "image":
       {"available_sizes":
         [[[150,
            135],
           "assets/images/resized/0027/4281/274281v1-max-150x150.jpg"],
          [[250,
            225],
           "assets/images/resized/0027/4281/274281v1-max-250x250.jpg"],
          [[450,
            405],
           "assets/images/resized/0027/4281/274281v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$30M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.syros.com/sites/default/files/Syros%20Pharmaceuticals%20Launches%20with%2030%20Million%20Series%20A%20Financing.pdf",
    "source_description": "Syros Pharmaceuticals Launches with $30 Million Series A Financing ",
    "raised_amount": 30000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 4,
    "funded_day": 11,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "ARCH Venture Partners",
         "permalink": "arch-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               31],
              "assets/images/resized/0003/6165/36165v2-max-150x150.png"],
             [[250,
               51],
              "assets/images/resized/0003/6165/36165v2-max-250x250.png"],
             [[300,
               62],
              "assets/images/resized/0003/6165/36165v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Flagship Ventures",
         "permalink": "flagship-ventures",
         "image":
          {"available_sizes":
            [[[150,
               34],
              "assets/images/resized/0002/8188/28188v4-max-150x150.png"],
             [[250,
               57],
              "assets/images/resized/0002/8188/28188v4-max-250x250.png"],
             [[323,
               74],
              "assets/images/resized/0002/8188/28188v4-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "480 Arsenal Street",
    "address2": "Suite 130 ",
    "zip_code": "02472",
    "city": "Watertown",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": 42.3650128,
    "longitude": -71.1606038}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}